Dow Jones -- Amgen Inc. signed an agreement with GlaxoSmithKline Plc to promote Amgen's anti-inflammatory treatment Enbrel to dermatologists in the U.S., as the drug faces increased competition in the area.
Dow Jones -- Amgen Inc. signed an agreement with GlaxoSmithKline Plc to promote Amgen's anti-inflammatory treatment Enbrel to dermatologists in the U.S., as the drug faces increased competition in the area.
